Research and development - Press Releases

Date	Title	Company
04-Oct-2022	InnoScot Health focusses in on ophthalmic innovation with new call	InnoScot Health
04-Oct-2022	Oxford BioTherapeutics enters into Commercial License Agreement with Genmab	Oxford BioTherapeutics
04-Oct-2022	President of The Physiological Society congratulates 2022 Nobel Prize winner	The Physiological Society
04-Oct-2022	Absolute Biotech Launches to Offer Antibody Reagents, Services and Expertise to Researchers Worldwide	Absolute Antibody
03-Oct-2022	Envision Pharma Group appoints Head of Envision Value & Access	Envision Pharma Group
03-Oct-2022	New Clinical Pharmacology Desktop Software Launched by Pumas-AI is Easier to Use and Compliant with Global Regulations	Pumas-AI
30-Sep-2022	Biognosys Expands Its Global Presence with a US Office in Biopharma Hub Cambridge, Massachusetts	Biognosys
30-Sep-2022	Kinarus Therapeutics Announces Discontinuation of the Phase 2 KINETIC Study of KIN001 in Hospitalized COVID-19 Patients Following a Prespecified Interim Analysis of Efficacy and Safety	Kinarus Therapeutics
30-Sep-2022	Biolog-id completed phase one of deploying its value-chain optimization solution in a multi-state integrated delivery network in the southeast USA	Biolog-id
28-Sep-2022	People Who Feel Less Pain Are Also Less Willing to Help Others	University of Vienna
28-Sep-2022	LifeArc Joins Forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to Strengthen Antimicrobial Discovery Efforts	Medicines Discovery Catapult
27-Sep-2022	Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.	EVERSANA
27-Sep-2022	Kepler Vision Technologies expands into Spain with three psychiatric hospital deployments	Kepler Vision Technologies
27-Sep-2022	SME competition offers Franklin expertise for research challenge	The Rosalind Franklin Institute
27-Sep-2022	Sosei Heptares to host R&D Day highlighting its innovative R&D and translational medicine approaches to drug discovery and strong pipeline momentum	Sosei Heptares
27-Sep-2022	Interim results for the six months ended 30 June 2022	BenevolentAI
27-Sep-2022	Prosoma Digital Therapeutics and EVERSANA Announce Commercialisation Partnership for New Therapeutic Supporting Mental Health and Behavioural Needs of Cancer Patients	Prosoma Digital Therapeutics
27-Sep-2022	Qlucore receives patent in Europe	Qlucore
27-Sep-2022	Investing in the Next Generation of Researchers, Beckman Coulter Life Sciences Announces Call for Grant Applications	Beckman Coulter Life Sciences
27-Sep-2022	Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2	Enzo Biochem